Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 4

2(28.6%)

Phase 3

1(14.3%)

7Total

N/A(4)

Phase 4(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05058612Phase 4Recruiting

Midodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site)

Role: collaborator

NCT05423652Not ApplicableActive Not Recruiting

Aiding COPD and CHF Ultrasound-guided Management Through ENhanced Point Of Care UltraSound

Role: collaborator

NCT04221932Completed

Implementation of CRRT KPI Reports to Standardize and Improve the Quality of CRRT Delivery in Alberta "QUALITY CRRT"

Role: collaborator

NCT04557501Phase 3Active Not Recruiting

PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer

Role: collaborator

NCT04489589Phase 4Completed

Midodrine for the Early Liberation of Vasopressor Support in the ICU

Role: collaborator

NCT00356655Not ApplicableTerminated

The ACHIEVA Study of Enhanced Pharmacist Care on Antidepressant Use and Response

Role: collaborator

NCT00457301Completed

Using Health-related Quality of Life (HRQL) in Routine Clinical Care

Role: collaborator

NCT02759874Not ApplicableUnknown

Prevention of Fetal Alcohol Spectrum Disorder (FASD) by the Use of Technology

Role: lead

NCT00175279Not ApplicableCompleted

A Cluster Randomized Trial to Assess the Impact of Opinion Leader Endorsed Evidence Summaries on Improving Quality of Prescribing for Patients With Chronic Cardiovascular Disease

Role: collaborator

All 9 trials loaded